LONDON – December 7, 2017 – On November 30, UBS Optimus Foundation and Palladium International Limited announced the formation of the world's first healthcare development impact bond, aimed to reduce mother and baby deaths in Rajasthan, India.  Acting for both Optimus - the philanthropic arm of UBS - and Palladium, Reed Smith LLP advised Optimus and Palladium on both the structuring and legal aspects of the DIB.

Related Professionals: Ranajoy Basu Priya Taneja Andrzej Janiszewski

Type: News Releases

Optimus will provide upfront funding up to $3.5 million over three years to Palladium, who will be managing the implementation of the DIB.  USAID and Merc for Mothers are Outcome Payers on the transaction.

This ground-breaking impact bond will focus on reducing the number of maternal and newborn deaths in Rajasthan, India. Rajasthan has one of the highest maternal and newborn mortality rates in the country, with 244 maternal deaths per 100,000 births and 47 infant deaths per 1000 live births. The Maternal and Newborn Health DIB – known as the ‘Utkrisht bond’, taken from the Hindi for ‘Excellence’ – will support government efforts to reduce maternal and newborn deaths by improving access to, and the quality of care in, up to 440 private healthcare facilities in Rajasthan.  The improvements are expected to benefit up to 600,000 women and could lead to more than 10,000 maternal and newborn lives being saved over five years.

The Reed Smith team was led by London-based partner Ranajoy Basu and included Andrzej Janiszewski (Counsel), Priya Taneja (Senior Associate) and Richelle Teo (Associate). The Reed Smith team had also advised Optimus on its first DIB, the three-year Educate Girls DIB that aims to keep girls from dropping out of schools and to improve education performance.